Women investors consistently outperform men largely due to more disciplined, long-term, and emotionally steady investing ...

SIP for Medical Education: Smart Planning Today Can Help You Meet Tomorrow's Rising MBBS Costs Pursuing a medical degree has ...

Patricia Louis is a content editor and social media strategist with a strong background in journalism, public relations and business. As the organic social media editor, she oversees and develops ...

Akron, OH – The Rubber Division, ACS is packing June with opportunities to strengthen your expertise and stay ahead in our rapidly evolving industry. From foundational courses to advanced topics and ...

The Food and Drug Administration on April 30 proposed excluding Novo Nordisk and Eli Lilly's weight-loss drugs from a key compounding list, potentially limiting large-scale production by outsourcing ...

FDA proposes excluding blockbuster weight-loss drugs from 503B compounding list Move could limit bulk production by outsourcing facilities Novo and Lilly support FDA stance If finalized, the move ...

“I have read many definitions of what is a conservationist, and written not a few myself, but I suspect that the best one is written not with a pen but with an axe.” As a Program in the Environment ...

I recently bumped into a financial adviser at the airport who was travelling home after several days of back-to-back client meetings. Markets were already fragile following the recent technology ...

Weight-loss company Noom has acquired 503A pharmacy Tailor Made Compounding, which Noom said will allow it to expand its behavior change programs and move beyond weight health. Tailor Made provides ...

Though it’s hard to say exactly what the future holds for mass GLP-1 compounding, the pressure is mounting from multiple angles in the U.S. as drugmakers and the FDA alike seek to crack down on the ...

Semaglutide treats type 2 diabetes and can support weight loss with diet and exercise. It works by mimicking glucagon-like peptide-1 (GLP-1) to boost insulin and reduce appetite. Compounded ...

The FDA is taking no prisoners as it continues its efforts to combat widespread GLP-1 drug compounding. In its latest offensive, the agency has unleashed a fresh set of 30 warning letters targeting ...